FDA Finds ‘Safety Signal’ of Seizures in Children 2-5 After COVID mRNA Vaccines

A new preprint study led by the U.S. Food and Drug Administration (FDA) has detected a potential “safety signal” for seizures and convulsions in young children after receiving the monovalent Pfizer or Moderna mRNA COVID-19 vaccines.

The median time between vaccination and seizures or convulsions was two days, with 32% occurring the day of or the day after vaccination.

The study reviewed 21 pre-specified health outcomes after exposure to the Pfizer, Moderna and Novavax monovalent COVID-19 vaccines in children 6 months to 17 years, and identified only these two safety signals as statistically significant.

First, despite the data described above, the authors concluded they did not find a strong pattern of clustering near the date of vaccination (day 0 or 1).

Approximately 56% of children 6 months to 17 years — a total of 40.5 million — have not received a first dose of the COVID-19 vaccine.

Vaccination for children under 12 began on Nov. 2, 2021, when the CDC recommended Pfizer’s vaccine for children ages 5-11. 

https://childrenshealthdefense.org/defender/fda-safety-signal-seizures-children-covid-mrna-vaccines/?utm_source=luminate&utm_medium=email&utm_campaign=defender-wk&utm_id=20231022